The Dubai plant will have an annual production capacity of 3 billion tablets, 15 million syrup bottles, and three million units of ointment, with plans to serve global volumes until 2030.
Arab Health Congress has announced a partnership with the Dubai Health Authority (DHA) as part of the Public Health Conference, to explore the future of healthcare by exploring cutting-edge technologies.
On behalf of the chairman of the board of directors of the Saudi Food and Drug Authority (SFDA), Saudi Arabia’s Minister of Economy and Planning Mr. Faisal bin Fadel Al-Ibrahim has signed a memorandum.
Dubai Health Authority's Informatics and Smart Health Department has unveiled the first Artificial Intelligence Policy for healthcare in the Emirate.
By Mountasser Kadrie, academic programme director for the Master of Healthcare Administration programme at Walden University’s College of Health Sciences.
UAE Ministry of Health and Prevention (MoHAP) has received the global accreditation certificate for The International Business Agility Model from the International Business Agility Institute (TIBAI).